Wall Street research analysts must be the most optimistic people on earth. They give "buy" ratings to more than half of public companies, even during the worst bear markets. They don't even give stocks a "hold" rating unless the company has made major missteps.
"Sell" ratings are rare and are only given when the sustainability of a company's business model is in serious question. When Wall Street analysts across multiple brokerages all start downgrading a stock, you know something is seriously wrong.
MarketBeat has compiled an exclusive list of the 12 most downgraded stocks on Wall Street right now. If any of these companies are lurking around in your portfolio, you will want to ask yourself "Why?". Wall Street analysts are abandoning these companies in droves. They are true "strong sell" stocks.
#1 - lululemon athletica (NASDAQ:LULU)
- Number of Downgrades
- 39 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.6
- Ratings Breakdown
- 18 Buy Ratings, 12 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $340.26 (48.8% Upside)
About lululemon athletica
Lululemon Athletica Inc, together with its subsidiaries, designs, distributes, and retails athletic apparel, footwear, and accessories under the lululemon brand for women and men. It offers pants, shorts, tops, and jackets for healthy lifestyle, such as yoga, running, training, and other activities. It also provides fitness-inspired accessories.
More about lululemon athletica
Recent Analyst Ratings
#2 - UnitedHealth Group (NYSE:UNH)
- Number of Downgrades
- 32 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.6
- Ratings Breakdown
- 16 Buy Ratings, 8 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $426.52 (39.0% Upside)
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
More about UnitedHealth Group
Recent Analyst Ratings
#3 - Sarepta Therapeutics (NASDAQ:SRPT)
- Number of Downgrades
- 29 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.5
- Ratings Breakdown
- 14 Buy Ratings, 11 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $70.76 (240.7% Upside)
About Sarepta Therapeutics
Sarepta Therapeutics, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene.
More about Sarepta Therapeutics
Recent Analyst Ratings
- Number of Downgrades
- 25 (in the last 90 days)
- Consensus Rating
- Hold
- Rating Score
- 2.0
- Ratings Breakdown
- 12 Buy Ratings, 10 Hold Ratings, 12 Sell Ratings.
- Consensus Price Target
- $66.20 (82.0% Upside)
About Enphase Energy
Enphase Energy, Inc, together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level and combines with its proprietary networking and software technologies to provide energy monitoring and control.
More about Enphase Energy
Recent Analyst Ratings
- Number of Downgrades
- 25 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.9
- Ratings Breakdown
- 39 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $710.00 (2.0% Upside)
About Meta Platforms
Meta Platforms, Inc engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately.
More about Meta Platforms
Recent Analyst Ratings
- Number of Downgrades
- 25 (in the last 90 days)
- Consensus Rating
- Hold
- Rating Score
- 2.2
- Ratings Breakdown
- 9 Buy Ratings, 24 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $116.70 (22.6% Upside)
About Target
Target Corporation operates as a general merchandise retailer in the United States. The company offers apparel for women, men, boys, girls, toddlers, and infants and newborns, as well as jewelry, accessories, and shoes; and beauty and personal care, baby gear, cleaning, paper products, and pet supplies.
More about Target
Recent Analyst Ratings
- Number of Downgrades
- 24 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.9
- Ratings Breakdown
- 44 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $244.89 (15.2% Upside)
About Amazon.com
Amazon.com, Inc engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content.
More about Amazon.com
Recent Analyst Ratings
- Number of Downgrades
- 24 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.8
- Ratings Breakdown
- 20 Buy Ratings, 8 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $113.63 (36.1% Upside)
About Elastic
Elastic N.V., a data analytics company, delivers solutions designed to run in public or private clouds in multi-cloud environments. It primarily offers Elastic Stack, a set of software products that ingest and store data from various sources and formats, as well as performs search, analysis, and visualization on that data.
More about Elastic
Recent Analyst Ratings
- Number of Downgrades
- 22 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.8
- Ratings Breakdown
- 22 Buy Ratings, 6 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $30.11 (25.8% Upside)
About Confluent
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
More about Confluent
Recent Analyst Ratings
- Number of Downgrades
- 22 (in the last 90 days)
- Consensus Rating
- Hold
- Rating Score
- 2.3
- Ratings Breakdown
- 20 Buy Ratings, 13 Hold Ratings, 9 Sell Ratings.
- Consensus Price Target
- $293.67 (8.8% Downside)
About Tesla
Tesla, Inc designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services.
More about Tesla
Recent Analyst Ratings
#11 - United Parcel Service (NYSE:UPS)
- Number of Downgrades
- 22 (in the last 90 days)
- Consensus Rating
- Hold
- Rating Score
- 2.4
- Ratings Breakdown
- 12 Buy Ratings, 12 Hold Ratings, 2 Sell Ratings.
- Consensus Price Target
- $120.26 (21.3% Upside)
About United Parcel Service
United Parcel Service, Inc, a package delivery company, provides transportation and delivery, distribution, contract logistics, ocean freight, airfreight, customs brokerage, and insurance services. It operates through two segments, U.S. Domestic Package and International Package. The U.S. Domestic Package segment offers time-definite delivery of express letters, documents, small packages, and palletized freight through air and ground services in the United States.
More about United Parcel Service
Recent Analyst Ratings
#12 - Westlake (NYSE:WLK)
- Number of Downgrades
- 22 (in the last 90 days)
- Consensus Rating
- Moderate Buy
- Rating Score
- 2.5
- Ratings Breakdown
- 7 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $90.54 (27.3% Upside)
About Westlake
Westlake Corporation engages in the manufacture and marketing of performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, Taiwan, and internationally. The company operates through two segments: Performance and Essential Materials and Housing and Infrastructure Products.
More about Westlake
Recent Analyst Ratings
More Investing Slideshows:
